» Authors » Katsumi Maenaka

Katsumi Maenaka

Explore the profile of Katsumi Maenaka including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 198
Citations 4198
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Liu Y, Mori T, Ito Y, Kuroki K, Hayashi S, Kohda D, et al.
J Control Release . 2025 Feb; 380:396-403. PMID: 39921032
Polyethylene glycol (PEG) is widely used as a standard stealth polymer, although the induction of anti-PEG antibodies and consequent effects have drawn attention in recent years. To date, several anti-PEG...
2.
Yamada C, Kuroki K, Maeda N, Watanabe H, Takahashi A, Maenaka K
Sci Rep . 2025 Jan; 15(1):2509. PMID: 39833185
Human leukocyte antigen (HLA)-G is a nonclassical HLA class I molecule that has an immunosuppressive effect mediated by binding to immune inhibitory leukocyte immunoglobulin-like receptors (LILR) B1 and LILRB2. A...
3.
Hama S, Watanabe-Takahashi M, Nishimura H, Omi J, Tamada M, Saitoh T, et al.
mBio . 2024 Nov; 16(1):e0008724. PMID: 39601535
Ca/calmodulin-dependent protein kinase II (CaMKII) is one of hundreds of host-cell factors involved in the propagation of type A influenza virus (IAV), although its mechanism of action is unknown. Here,...
4.
Sasaki J, Sato A, Sasaki M, Okabe I, Kodama K, Otsuguro S, et al.
Antiviral Res . 2024 Nov; 232:106039. PMID: 39571911
Coronaviruses such as the Middle East respiratory syndrome coronavirus (MERS-CoV), severe acute respiratory syndrome coronavirus (SARS-CoV), and SARS-CoV-2, causing MERS, SARS, and Coronavirus disease-19, respectively, are highly pathogenic to humans....
5.
Matsumaru T, Iwamatsu T, Ishigami K, Inai M, Kanto W, Ishigaki A, et al.
Chem Biol Drug Des . 2024 Oct; 104(4):e70002. PMID: 39438141
Splicing modulation by a small compound offers therapeutic potential for diseases caused by splicing abnormality. However, only a few classes of compounds that can modulate splicing have been identified. We...
6.
Yajima H, Anraku Y, Kaku Y, Kimura K, Plianchaisuk A, Okumura K, et al.
Nat Commun . 2024 Oct; 15(1):8574. PMID: 39375326
Since 2019, SARS-CoV-2 has undergone mutations, resulting in pandemic and epidemic waves. The SARS-CoV-2 spike protein, crucial for cellular entry, binds to the ACE2 receptor exclusively when its receptor-binding domain...
7.
Yajima H, Nomai T, Okumura K, Maenaka K, Ito J, Hashiguchi T, et al.
mBio . 2024 Sep; 15(10):e0322023. PMID: 39283095
Due to the incessant emergence of various SARS-CoV-2 variants with enhanced fitness in the human population, controlling the COVID-19 pandemic has been challenging. Understanding how the virus enhances its fitness...
8.
Li R, Zhang S, Otsuguro S, Nagao M, Matsuda A, Thapa J, et al.
Biochem Biophys Res Commun . 2024 Aug; 736:150461. PMID: 39128263
To understand why Chlamydia trachomatis (Ct) (L2/434/Bu) favors hypoxia, we examined the dynamics of infected cells using a glycolysis-related PCR array and metabolomic analysis, along with the perturbation of nucleotide...
9.
Fukuhara H, Yumoto K, Sako M, Kajikawa M, Ose T, Kawamura M, et al.
Elife . 2024 Jul; 12. PMID: 39046448
Canine distemper virus (CDV) belongs to morbillivirus, including measles virus (MeV) and rinderpest virus, which causes serious immunological and neurological disorders in carnivores, including dogs and rhesus monkeys, as recently...
10.
Tsujino S, Deguchi S, Nomai T, Padilla-Blanco M, Plianchaisuk A, Wang L, et al.
Microbiol Immunol . 2024 Jul; 68(9):305-330. PMID: 38961765
In middle to late 2023, a sublineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Omicron XBB, EG.5.1 (a progeny of XBB.1.9.2), is spreading rapidly around the world. We performed...